ElizabethABarrancoMD

Internal Medicine • Ponce, PR

Infectious Disease

Associate Professor, Medicine, Ponce SOM and Health Sciences

Join to view full profile

Dr. Barranco is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Barranco's full profile

Already have an account?

Office
280 Calle Monterrey
Ponce, PR 00716
Phone+1 787-840-2505

Fax+1 787-840-2535
Is this information wrong?

Education & Training

Albany Medical CenterFellowship, Infectious Disease, 1986 - 1988
Southside Medical CenterResidency, Internal Medicine, 1983 - 1986
Universidad Central del Caribe School of MedicineClass of 1982

Certifications & Licensure

PR State Medical License 1997 - 2025
OH State Medical License 1985 - 1986

Clinical Trials

Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a Flavivirus Endemic Area Start of enrollment: 2017 Mar 21
Completed
Phase 1

Publications & Presentations

PubMed

34 citations
Combination therapy with various combinations of aliskiren, valsartan, and hydrochlorothiazide in hypertensive patients not adequately responsive to hydrochlorothiazid...
Helmut Geiger, Elizabeth Barranco, Manuel Gorostidi, Addison A. Taylor, Xiaoli Zhang, Zhihua Xiang, Jack Zhang> ;Journal of Clinical Hypertension. 2009 Jun 1